Similar Papers

Paper Title
Journal
Date
Author
Regulation of the programmed cell death protein 1/programmed cell death ligand 1 axis in relapsing-remitting multiple sclerosis.
Thanos Tsaktanis ... Lucy Nirschl
Brain Communications | VOL. 5
Thanos Tsaktanis, et. al.Thanos Tsaktanis ... Lucy Nirschl
01 Jul 2023
High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial.
...
Leukemia | VOL. 28
, et. al. ...
15 Apr 2014
Elevated serum soluble programmed cell death ligand 1 concentration as a potential marker for poor prognosis in small cell lung cancer patients with chemotherapy
Jianjun Jin ... Jiming Si
Respiratory Research | VOL. 19
Jianjun Jin, et. al.Jianjun Jin ... Jiming Si
05 Oct 2018
The expression and clinical significance of serum soluble programmed cell death ligand-1 in adult patients with community-acquired pneumonia
...
Zhonghua nei ke za zhi | VOL. 60
, et. al. ...
01 Mar 2021
View more papers

More From: Frontiers in Oncology

Paper Title
Journal
Date
Author
Antiangiogenic therapy with recombinant human endostatin may improve blood perfusion of cervical node with necrosis in nasopharyngeal carcinoma patients: a preliminary study by using contrast-enhanced ultrasound
Zhendong Yang ... Jianyuan Huang
Frontiers in Oncology | VOL. -
Zhendong Yang, et. al.Zhendong Yang ... Jianyuan Huang
31 Jan 2025
Prognostic and clinicopathological role of soluble programmed cell death ligand-1 in patients with diffuse large B-cell lymphoma: a meta-analysis
Hongbin Lu ... Wenwen Ding
Frontiers in Oncology | VOL. -
Hongbin Lu, et. al.Hongbin Lu ... Wenwen Ding
31 Jan 2025
Adeno-associated virus mediated artificial circular RNA for triggering cancer immunotherapy to treat prostate cancer
Chujin Ye ... Haibiao Xie
Frontiers in Oncology | VOL. -
Chujin Ye, et. al.Chujin Ye ... Haibiao Xie
31 Jan 2025
Oncocytic papillary renal cell carcinoma (OPRCC): 2 case report and literature review
Yanchen Wang ... Yaofei Sun
Frontiers in Oncology | VOL. -
Yanchen Wang, et. al.Yanchen Wang ... Yaofei Sun
31 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.